Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Completed · Phase 2

Conditions studied: Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma

In brief

The purpose of this study is to evaluate the tolerability of intraperitoneal cisplatin with intravenous paclitaxel and Avastin as defined by the proportion of patients able to complete 6 cycles of treatment.

Key facts

Study ID

NCT00511992

Run by

University of Oklahoma

People needed

20

Starts

2007-07-01

Expected to finish

2015-08-03

Last updated by the study team

2017-07-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with stage II and III epithelial ovarian carcinoma, primary peritoneal carcinoma, or ovarian carcinosarcoma.
• Adequate bone marrow, renal, and hepatic function
• Patients must be entered no more than twelve weeks postoperatively

You may not qualify if…

• Patients with epithelial ovarian carcinoma of low malignant potential (borderline carcinomas).
• Stage IV or suboptimally debulked disease following primary cytoreductive surgery
• Patients who have received prior radiotherapy or chemotherapy.

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.